Show simple item record

dc.contributor.authorMahmud, E.
dc.contributor.authorDauerman, H.L.
dc.contributor.authorMattu, A.
dc.date.accessioned2020-05-08T20:13:25Z
dc.date.available2020-05-08T20:13:25Z
dc.date.issued2020-04-20
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85083983304&doi=10.1002%2fccd.28946&partnerID=40&md5=82472a0ed6d3221f457d7f1ad830e4fd
dc.identifier.urihttp://hdl.handle.net/10713/12717
dc.description.abstractThe worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 (SARS-CoV2) has resulted in a new and lethal disease termed coronavirus disease 2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with COVID-19. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating a ST-elevation MI presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury and the prevalence of COVID-19 disease in the US population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.en_US
dc.description.urihttps://doi.org/10.1002/ccd.28946en_US
dc.language.isoen_USen_US
dc.publisherJohn Wiley and Sons Inc.en_US
dc.relation.ispartofCatheterization and Cardiovascular Interventions
dc.subjectacute myocardial infarctionen_US
dc.subjectCOVID-19en_US
dc.subjectemergency medical systemen_US
dc.subjectfibrinolysisen_US
dc.subjectpercutaneous coronary interventionen_US
dc.subjectSTEMIen_US
dc.titleManagement of Acute Myocardial Infarction During the COVID-19 Pandemicen_US
dc.typeArticleen_US
dc.identifier.doi10.1002/ccd.28946
dc.identifier.pmid32311816


This item appears in the following Collection(s)

Show simple item record